Carlos Garcia-Parada - Sep 13, 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Chief Financial Officer
Signature
/s/ Carlos Garcia-Parada
Stock symbol
RCKT
Transactions as of
Sep 13, 2021
Transactions value $
$0
Form type
4
Date filed
9/15/2021, 04:07 PM
Next filing
Feb 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +40K $0.00 40K Sep 13, 2021 Common Stock 40K $35.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on September 13, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.